Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with <i>Pten</i> Haploinsufficiency in Mice Fed High‐Fat Diet

  • Tanvi Joshi
    Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Brooklyn NY 11201 USA
  • Ishani Patel
    Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Brooklyn NY 11201 USA
  • Avinash Kumar
    Arnold & Marie Schwartz College of Pharmacy and Health Sciences Long Island University Brooklyn NY 11201 USA
  • Virginia Donovan
    NYU Winthrop Hospital Mineola NY 11501 USA
  • Anait S. Levenson
    School of Veterinary Medicine Long Island University Brookville NY 11548 USA

抄録

<jats:sec><jats:title>Scope</jats:title><jats:p>Previous studies have identified potent anticancer activities of polyphenols in preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive potential of grape powder (GP) supplemented diets in genetically predisposed and obesity‐provoked prostate cancer.</jats:p></jats:sec><jats:sec><jats:title>Methods and results</jats:title><jats:p>Prostate‐specific <jats:italic>Pten</jats:italic> heterozygous (<jats:italic>Pten</jats:italic><jats:sup>+/f</jats:sup>) transgenic mice are fed low‐ and high‐fat diet (LFD and HFD, respectively) supplemented with 10% GP for 33 weeks, ad libitum. Prostate tissues are characterized using immunohistochemistry and western blots, and sera are analyzed by ELISA and qRT‐PCR. <jats:italic>Pten</jats:italic><jats:sup>+/f</jats:sup> mice fed LFD and HFD supplemented with 10% GP show favorable histopathology, significant reduction of the proliferative rate of prostate epithelial cells (Ki67), and rescue of PTEN expression. The most potent protective effect of GP supplementation is detected against HFD‐induced increase in inflammation (IL‐1β; TGF‐β1), activation of cell survival pathways (Akt, AR), and angiogenesis (CD31) in <jats:italic>Pten</jats:italic><jats:sup>+/f</jats:sup> mice. Moreover, GP supplementation reduces circulating levels of oncogenic microRNAs (miR‐34a; miR‐22) in <jats:italic>Pten</jats:italic><jats:sup>+/f</jats:sup> mice. There are no significant changes in body weight and food intake in GP supplemented diet groups.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>GP diet supplementation can be a beneficial chemopreventive strategy for obesity‐related inflammation and prostate cancer progression. Monitoring serum miRNAs can facilitate the non‐invasive evaluation of chemoprevention efficacy.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

キーワード

問題の指摘

ページトップへ